These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24630408)

  • 1. Impaired cholesterol efflux capacity and vasculoprotective function of high-density lipoprotein in heart transplant recipients.
    Singh N; Jacobs F; Rader DJ; Vanhaecke J; Van Cleemput J; De Geest B
    J Heart Lung Transplant; 2014 May; 33(5):499-506. PubMed ID: 24630408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic inflammation and metabolic syndrome in cardiac allograft vasculopathy.
    Raichlin ER; McConnell JP; Lerman A; Kremers WK; Edwards BS; Kushwaha SS; Clavell AL; Rodeheffer RJ; Frantz RP
    J Heart Lung Transplant; 2007 Aug; 26(8):826-33. PubMed ID: 17692787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol efflux capacity of high-density lipoprotein correlates with survival and allograft vasculopathy in cardiac transplant recipients.
    Javaheri A; Molina M; Zamani P; Rodrigues A; Novak E; Chambers S; Stutman P; Maslanek W; Williams M; Lilly SM; Heeger P; Sayegh MH; Chandraker A; Briscoe DM; Daly KP; Starling R; Ikle D; Christie J; Rame JE; Goldberg LR; Billheimer J; Rader DJ
    J Heart Lung Transplant; 2016 Nov; 35(11):1295-1302. PubMed ID: 27498384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between systemic inflammation and markers of insulin resistance in cardiovascular prognosis after heart transplantation.
    Biadi O; Potena L; Fearon WF; Luikart HI; Yeung A; Ferrara R; Hunt SA; Mocarski ES; Valantine HA
    J Heart Lung Transplant; 2007 Apr; 26(4):324-30. PubMed ID: 17403472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating apoptotic endothelial cells and apoptotic endothelial microparticles independently predict the presence of cardiac allograft vasculopathy.
    Singh N; Van Craeyveld E; Tjwa M; Ciarka A; Emmerechts J; Droogne W; Gordts SC; Carlier V; Jacobs F; Fieuws S; Vanhaecke J; Van Cleemput J; De Geest B
    J Am Coll Cardiol; 2012 Jul; 60(4):324-31. PubMed ID: 22813611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation.
    Arora S; Gullestad L; Wergeland R; Simonsen S; Holm T; Hognestad A; Ueland T; Geiran O; Andreassen A
    Transplantation; 2007 May; 83(10):1308-15. PubMed ID: 17519779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early inflammatory markers are independent predictors of cardiac allograft vasculopathy in heart-transplant recipients.
    Labarrere CA; Woods JR; Hardin JW; Jaeger BR; Zembala M; Deng MC; Kassab GS
    PLoS One; 2014; 9(12):e113260. PubMed ID: 25490200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-density lipoprotein mediated cellular cholesterol efflux in acute coronary syndromes.
    Hafiane A; Jabor B; Ruel I; Ling J; Genest J
    Am J Cardiol; 2014 Jan; 113(2):249-55. PubMed ID: 24210679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated HDL cholesterol is functionally ineffective in cardiac transplant recipients: evidence for impaired reverse cholesterol transport.
    Sviridov D; Chin-Dusting J; Nestel P; Kingwell B; Hoang A; Olchawa B; Starr J; Dart A
    Transplantation; 2006 Feb; 81(3):361-6. PubMed ID: 16477221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In the era of the universal use of statins dyslipidemia's are still common in heart transplant recipients: a cross-sectional study.
    Zakliczynski M; Boguslawska J; Wojniak E; Zakliczynska H; Ciesla D; Nozynski J; Szygula-Jurkiewicz B; Zeglen S; Zembala M
    Transplant Proc; 2011 Oct; 43(8):3071-3. PubMed ID: 21996228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low HDL-C predicts the onset of transplant vasculopathy in pediatric cardiac recipients on pravastatin therapy.
    Hedman M; Pahlman R; Sundvall J; Ehnholm C; Syvänne M; Jokinen E; Jauhiainen M; Holmberg C; Antikainen M
    Pediatr Transplant; 2007 Aug; 11(5):481-90. PubMed ID: 17631015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function.
    Petrakopoulou P; Kübrich M; Pehlivanli S; Meiser B; Reichart B; von Scheidt W; Weis M
    Circulation; 2004 Sep; 110(11 Suppl 1):II207-12. PubMed ID: 15364864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up study on the utility of von Willebrand factor levels in the diagnosis of cardiac allograft vasculopathy.
    Martínez-Dolz L; Almenar L; Reganon E; Vila V; Chamorro C; Andrés L; Martínez-Sales V; Moro J; Agüero J; Sánchez-Lázaro I; Salvador A
    J Heart Lung Transplant; 2008 Jul; 27(7):760-6. PubMed ID: 18582806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmunity to vimentin potentiates graft vasculopathy in murine cardiac allografts.
    Mahesh B; Leong HS; Nair KS; McCormack A; Sarathchandra P; Rose ML
    Transplantation; 2010 Jul; 90(1):4-13. PubMed ID: 20463646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelium-enriched microRNAs as diagnostic biomarkers for cardiac allograft vasculopathy.
    Singh N; Heggermont W; Fieuws S; Vanhaecke J; Van Cleemput J; De Geest B
    J Heart Lung Transplant; 2015 Nov; 34(11):1376-84. PubMed ID: 26198441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of metabolic syndrome on development of cardiac allograft vasculopathy in the transplanted heart.
    Sánchez-Gómez JM; Martínez-Dolz L; Sánchez-Lázaro I; Almenar L; Sánchez-Lacuesta E; Muñoz-Giner B; Portolés M; Rivera M; Valera-Román A; González-Juanatey JR; Tejada-Ponce D; Agüero J; Buendía F; Salvador A
    Transplantation; 2012 Jan; 93(1):106-11. PubMed ID: 22134367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol efflux and metabolic abnormalities associated with low high-density-lipoprotein-cholesterol and high triglycerides in statin-treated coronary men with low-density lipoprotein-cholesterol <70 mg/dl.
    Posadas-Sánchez R; Posadas-Romero C; Mendoza-Pérez E; Caracas-Portilla NA; Cardoso-Saldaña G; Medina-Urrutia A; Jorge-Galarza E; Juárez-Rojas JG
    Am J Cardiol; 2012 Mar; 109(5):636-41. PubMed ID: 22169129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated uric acid levels predict allograft vasculopathy in cardiac transplant recipients.
    Kittleson MM; Bead V; Fradley M; St John ME; Champion HC; Kasper EK; Russell SD; Wittstein IS; Hare JM
    J Heart Lung Transplant; 2007 May; 26(5):498-503. PubMed ID: 17449420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac allograft vasculopathy in pediatric heart transplant recipients.
    Hathout E; Beeson WL; Kuhn M; Johnston J; Fitts J; Razzouk A; Bailey L; Chinnock RE
    Transpl Int; 2006 Mar; 19(3):184-9. PubMed ID: 16441766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association between serum NT-proBNP/hs-CRP and acute rejection after heart transplantation].
    Yin D; Huang J; Feng L; Feng GX; Hu SS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Feb; 37(2):145-8. PubMed ID: 19719993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.